Related Experiment Videos
Asthma in children
1Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206.
Insights
Childhood asthma remains a significant health concern, with potential for increased mortality due to improper medication use. Optimal asthma therapy requires an open mind, considering both anti-inflammatory and beta-agonist treatments.
Area of Science:
- Pediatric Pulmonology
- Allergy and Immunology
- Respiratory Medicine
Background:
- Childhood asthma continues to cause significant morbidity and mortality despite medical advances.
- Over-reliance on beta-agonists and underutilization of anti-inflammatory drugs are linked to increased asthma mortality in children.
- Airway inflammation, even in mild asthma, and its impact on airway responsiveness are increasingly recognized.
Purpose of the Study:
- To highlight the challenges in managing childhood asthma.
- To emphasize the need for a comprehensive approach to asthma therapy.
- To advocate for an open-minded strategy in treating severe pediatric asthma.
Main Methods:
- Review of current understanding of asthma pathophysiology and treatment.
- Analysis of the impact of medication overuse and underuse on asthma outcomes.
- Consideration of clinical observations in severe pediatric asthma cases.
Main Results:
- Current anti-inflammatory medications are not universally effective for all pediatric asthma patients.
- Appropriate corticosteroid use does not always resolve chronic severe asthma in children.
- The complexity of asthma suggests current therapeutic concepts may be too simplistic.
Conclusions:
- Healthcare providers must remain flexible in their approach to optimal asthma management.
- A personalized and adaptive therapeutic strategy is crucial for severe childhood asthma.
- Further research into novel and effective anti-inflammatory agents is warranted.
Abstract:
Despite advances in the understanding of asthma, there is still a high rate of morbidity and mortality from this disease in children. Although many factors are involved, a persistent concern is that the overuse of beta-agonists combined with the underuse of antiinflammatory medications leads to increased mortality. The demonstration that airway inflammation is present in mild asthma and the observations that inflammatory stimuli increase airway responsiveness have led to the use of antiinflammatory agents at earlier stages of disease. However, the medications with antiinflammatory activity that are currently available are not effective for all patients. The problems posed by chronic severe asthma in a child despite appropriate use of corticosteroids suggest that our current concepts are overly simplistic. Therefore, health care workers dealing with this disease must maintain an open mind about what constitutes optimal therapy.